SOSTOYaNIE KOSTNOY TKANI I RISK RAZVITIYa OSTEOPOROZA U ZhENShchIN V STADII POLNOY REMISSIIBOLEZNI ITsENKO-KUShINGA NA FONE FIZIOLOGIChESKOYMENOPAUZY
https://doi.org/10.14341/osteo2007313-20
Abstract
It is well known that clinical signs of endogenous hypercorticism including secondary osteoporosis rapidly reverse on the base of hormonal remission after radiosurgical treatment of Cushing's disease (CD). The aim of the study was to assess BMD and bone turnover biochemical markers in postmenopausal women with complete CD-remission.
We examined 43 women aged 38-67 years in physiological postmenopause who had a complete long-term hormonal CD-remission for at least 2 years (11±6,8 years in average) after combine treatment with hemiadrenalectomy and radiosurgery. Control group comprised 98 healthy postmenopausal women at the same age and postmenopausal age.
Our main findings were BMD in postmenopausal CD-patients was higher vs. controls in lumbar spine (1,233±0,17 vs. 1,146±0,20 g/cm2, p<0,05), trochanter (0,873±0,15 vs. 0,809±0,15 g/cm2, p<0,05) and total proximal femur (1,067±0,16 vs. 0,949±0,21 g/cm2, p<0,01). Frequency of normal BMD was significantly higher in spine (93%), trochanter (93%), total proximal femur (93%) and distal forearm (81%) in CD-group vs. control (62%, 76%, 77% and 59% accordingly, p<0,05). There was also revealed a lower frequency of osteopenia in spine (14%), trochanter (7%) and distal forearm (14%) in CD-group vs. control (32%, 23% and 33% accordingly, p<0,05), although incidence of vertebral deformities were more in CD-group (37%) vs. control (18%, p<0,05). We found significantly lower levels of CTx (p<0,001) and osteocalcin (p<0,01) in CD-patients vs. controls. A maximal BMD gain was observed in patients with CD remission about 4-5 years and BMD significantly decreased in women with CD-remission more than 12 years. CD-women with postmenopausal age 2-10 years had significantly higher BMD vs. associate control postmenopausal women. Marked BMD lowering was observed in CD-women only after 10 years of menopause. Age, postmenopausal age, low body weight and duration of remission were evaluated as main risk factors for osteoporosis in women with complete CD-remission.
Our result demonstrate that postmenopausal women with complete CD-remission have higher BMD and lower bone turnover than healthy postmenopausal women of the same age and maximal increase in BMD is observed at about 5 years of complete CD-remission.
We examined 43 women aged 38-67 years in physiological postmenopause who had a complete long-term hormonal CD-remission for at least 2 years (11±6,8 years in average) after combine treatment with hemiadrenalectomy and radiosurgery. Control group comprised 98 healthy postmenopausal women at the same age and postmenopausal age.
Our main findings were BMD in postmenopausal CD-patients was higher vs. controls in lumbar spine (1,233±0,17 vs. 1,146±0,20 g/cm2, p<0,05), trochanter (0,873±0,15 vs. 0,809±0,15 g/cm2, p<0,05) and total proximal femur (1,067±0,16 vs. 0,949±0,21 g/cm2, p<0,01). Frequency of normal BMD was significantly higher in spine (93%), trochanter (93%), total proximal femur (93%) and distal forearm (81%) in CD-group vs. control (62%, 76%, 77% and 59% accordingly, p<0,05). There was also revealed a lower frequency of osteopenia in spine (14%), trochanter (7%) and distal forearm (14%) in CD-group vs. control (32%, 23% and 33% accordingly, p<0,05), although incidence of vertebral deformities were more in CD-group (37%) vs. control (18%, p<0,05). We found significantly lower levels of CTx (p<0,001) and osteocalcin (p<0,01) in CD-patients vs. controls. A maximal BMD gain was observed in patients with CD remission about 4-5 years and BMD significantly decreased in women with CD-remission more than 12 years. CD-women with postmenopausal age 2-10 years had significantly higher BMD vs. associate control postmenopausal women. Marked BMD lowering was observed in CD-women only after 10 years of menopause. Age, postmenopausal age, low body weight and duration of remission were evaluated as main risk factors for osteoporosis in women with complete CD-remission.
Our result demonstrate that postmenopausal women with complete CD-remission have higher BMD and lower bone turnover than healthy postmenopausal women of the same age and maximal increase in BMD is observed at about 5 years of complete CD-remission.
About the Authors
L A MARChENKOVAA V DREVAL'
E Yu POLYaKOVA
R S TIShENINA
N M MYLOV
I P ERMAKOVA
I A PRONChENKO
V P BUZULINA
M P RUBIN
References
1. Андреева Е.Н., Карпова Е.А. Репродуктивная функция у женщин и ожирение. // В кн. Ожирение. Под ред. Дедова И.И., Мельниченко Г.А. - М.: МИА, 2004. - С. 159-184.
2. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. // РМЖ, 2001. - № 2 (9). - С. 56-60.
3. Бухман А.И. Рентгенодиагностика в эндокринологии. - М.: Медицина, 1975.
4. Марова Е.И. Достижения в диагностике и лечении болезни Иценко-Кушинга. // В кн.: Нейроэндокринология. Под ред. Е.И. Маровой. Ярославль: «ДИА-пресс». - 1999. - С. 81-144.
5. Риггз Б.Л., Мелтон III.Д. Остеопороз. Пер. с англ. М. - СПб.: ЗАО «Издательство БИНОМ», «Невский диалект». - 2000. - С. 560.
6. Рожинская Л.Я. Минеральная плотность ткани при эндогенном и экзогенном гипрекортицизме // Остеопороз и остеопатии. - 2000, № 2. - С.12-17.
7. Рожинская Л.Я. Остеопенический синдром при заболеваниях эндокринной системы и постменопаузальный остеопороз (патогенетические аспекты, диагностика и лечение): Дис. д-ра мед. наук. М., 2001.
8. Сметник В.П., Шестакова И.Г. Менопаузальный метаболический синдром. // В кн. Медицина климактерия. Под ред. Сметник В.П. - Ярославль: «Издательство Литера». - 2006. - С. 570-625.
9. Франке Ю., Рунге Г. Остеопороз // Пер. с нем. - М.: Медицина. - 1995. - С. 304.
10. Caro J.F. // Leptin: from 1958 to present. - Canadian Journal of Diabetes Care. - 1998 - Vol. 22. - P. 18-23.
11. Cizza G., Lotsikas A.J., Licino J. et al. Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism. // J. Clin. Endocrinol.Metab. - 1997. - Vol. 82 (8). - P. 2747-2750.
12. Filip R.S., Raszewski G., Haratym-Maj A. et al. Biochemical markers of bone metabolism and serum leptin in obese postmenopausal women. // Bone. - 2005. - Vol.36. - Suppl. 2. - P. S 152 - S153.
13. Joint Meeting of the European Calcified Tissue Society and the International Bone and Mineral Society.
14. Garnero P., Sornay-Rendu E., Chapuy M.C. et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. // J. Bone miner. Res. - 1996. - Vol. 11. - P. 337-349.
15. Lukert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management. // Ann. Intern. Med. - 1990. - Vol. 112 (5). - P. 353-364.
16. Luengo M., Picado C., Del Rio L., et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. // Thorax. - 1991. - Vol. 46 (11). - P. 803-806.
17. Manning P. J., Evans M.C., Reid I.R. Normal bone mineral density following cure of Cushing's syndrome. // Clin. Endocrinol. - 1992. - Vol. 36 - P. 229-234.
18. Meunier P.J., Dempster D.W., Edouard C. et al. Bone histomorphometry in corticosteriod-induced osteoporosis in Cushing'syndrome. - Advance in Exper. Med. Biol. - 1984. - Vol.171. - P. 191-200.
19. Nordin B.E.C. Calcium, phosphate and magnesium metabolism. // Edinburgh. - 1976. - P. 469-500.
20. Van Staa T.P., Leufkens H.G.M., Cooper C. The epidemiology of corticosteroid-induced osteoporosis. // Osteoporos. Int. - 2002. - Vol.13. - P. 777-787.
21. Verthoven A.C. and Boens M. Limited bone loss due corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases. // J. Rheumatjl. - 1997. - Vol.24. - P. 1495-1503.
22. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. - WHO. - Geneva. - Switzerland: WHO - 1994.
Review
For citations:
MARChENKOVA L.A., DREVAL' A.V., POLYaKOVA E.Yu., TIShENINA R.S., MYLOV N.M., ERMAKOVA I.P., PRONChENKO I.A., BUZULINA V.P., RUBIN M.P. SOSTOYaNIE KOSTNOY TKANI I RISK RAZVITIYa OSTEOPOROZA U ZhENShchIN V STADII POLNOY REMISSIIBOLEZNI ITsENKO-KUShINGA NA FONE FIZIOLOGIChESKOYMENOPAUZY. Osteoporosis and Bone Diseases. 2007;10(3):13-20. (In Russ.) https://doi.org/10.14341/osteo2007313-20
Views:
364
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
